Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ILIU > SEC Filings for ILIU > Form 8-K on 13-Aug-2013All Recent SEC Filings

Show all filings for INTERLEUKIN GENETICS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INTERLEUKIN GENETICS INC


13-Aug-2013

Change in Directors or Principal Officers, Amendments to Articles of Inc


Item 5.02. Departure of Directors or Certain Officers; Election Of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On August 9, 2013, at the 2013 Annual Meeting of Stockholders (the "Annual Meeting") of Interleukin Genetics, Inc. (the "Company"), the shareholders approved the Company's 2013 Employee, Director and Consultant Equity Incentive Plan (the "Stock Plan"), as described under Proposal 4 of Item 5.07 below. A description of the terms and conditions of the Stock Plan is set forth in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 24, 2013 (the "Proxy Statement") under the heading "Proposal 4: Approval of the 2013 Employee, Director and Consultant Equity Incentive Plan," and is incorporated herein by reference. Such description is qualified in its entirety by reference to the actual terms of the Stock Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K.



Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On August 9, 2013, the Company filed a certificate of amendment to its Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company's common stock from 150,000,000 to 300,000,000. The certificate of amendment became effective upon filing. A copy of the certificate of amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.



Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, at which a quorum was present, the stockholders of the Company voted on and approved the following matters, which are described in detail in the Proxy Statement: (1) to elect William C. Mills III and James M. Weaver as Class I directors to each serve for a three-year term expiring at the Company's 2016 annual meeting of stockholders ("Proposal 1"); (2) to approve an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 150,000,000 to 300,000,000 ("Proposal 2"); (3) to approve an amendment to the Company's Certificate of Incorporation, as amended, to effect a reverse stock split by combining outstanding shares of the Company's common stock into a lesser number of outstanding shares by a ratio of not less than 1-for-5 and not more than 1-for-20 at any time prior to the earlier of (i) August 1, 2014 and (ii) the 2014 annual meeting of stockholders, with the exact ratio to be set within this range by the Company's board of directors in its sole discretion ("Proposal 3");
(4) to approve the 2013 Employee, Director and Consultant Equity Incentive Plan("Proposal 4"); (5) to ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2013 ("Proposal 5"); (6) to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement ("Proposal 6"); and (7) to approve, on an advisory basis, the frequency of having an advisory vote on the compensation of the Company's named executive officers ("Proposal 7").

The tabulation of votes with respect to the proposals was as follows:

Proposal 1 - Election of Directors:



                          For       Withheld   Broker Non-Votes
William C. Mills III   93,834,898    85,929       21,642,269
James M. Weaver        93,717,214   203,613       21,642,269

Proposal 2 - Amendment of the Company's Certificate of Incorporation (Authorized Common Stock Increase):

For Against Abstain
113,386,951 1,831,708 344,437

Proposal 3 - Amendment of the Company's Certificate of Incorporation (Reverse Stock Split):

For Against Abstain
109,326,781 5,269,665 966,650

Proposal 4 - Approval of 2013 Employee, Director and Consultant Equity Incentive Plan:

For Against Abstain Broker Non-Votes 93,482,922 275,887 162,018 21,642,269

Proposal 5 - Ratification of Independent Registered Public Accounting Firm:

For Against Abstain
115,474,144 88,068 884

Proposal 6 - Advisory Vote on Approval of Executive Compensation:

For Against Abstain Broker Non-Votes 93,662,141 87,953 170,733 21,642,269

Proposal 7 - Advisory Vote on the Frequency of Having an Advisory Vote on the Compensation of Named Executive Officers:

Every Year Every 2 Years Every 3 Years Abstain Broker Non-Votes 91,617,701 2,063,152 119,257 120,717 21,642,269

Consistent with the recommendation of the board of directors in the Proxy Statement and the stockholder votes at the Annual Meeting, the board of directors has determined to hold a non-binding, advisory vote on the compensation of the Company's named executive officers every year until the earlier of (1) the next required vote on the frequency of such advisory vote, which is currently expected to be held at our 2019 annual meeting of stockholders; or (2) such date that the board of directors decides to hold the next stockholder advisory vote on the frequency of such advisory votes.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

3.1 Certificate of Amendment filed with the Delaware Secretary of State on August 9, 2013.

10.1+ 2013 Employee, Director and Consultant Equity Incentive Plan.
+ Management contract or compensatory plan arrangement

  Add ILIU to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ILIU - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.